- 中国精品科技期刊
- 中国高校百佳科技期刊
- 中国中文核心期刊
- 中国科学引文数据库核心期刊
| Citation: |
SHANG Feiyang, LIU Chengbo, TAN Hongzhou, et al. Design, synthesis and antiplatelet aggregation activity of 3-acetyl-7-hydroxycoumarin derivatives[J]. J China Pharm Univ, 2024, 55(3): 367 − 374. DOI: 10.11665/j.issn.1000-5048.2023072901
|
In order to search for coumarin-based anti-platelet aggregation compounds with high efficacy and good druggability, twenty-five 3-acetyl-7-hydroxy-coumarin oxime derivatives (6a-6y) were synthesized via Vilsmeier-Haack reaction, Knoevenagel reaction, Williamson reaction, electrophilic substitution reaction and oximation reaction from resorcinol. Their structures were confirmed by HRMS and 1H NMR spectra. The anti-platelet aggregation activity of the target compounds was evaluated using Born’s turbidimetric method. The results revealed that most of them could significantly inhibit platelet aggregation induced by adenosine diphosphate (ADP), collagen, arachidonic acid (AA) and thrombin. Among them, the target compounds 6a and 6b not only had strong inhibitory activity on platelet aggregation induced by the four inducers, but also exhibited good water solubility (3.46 mg/mL and 3.85 mg/mL, respectively) and lipid-water partition coefficient (2.56 and 2.85, respectively) and were expected to become a preclinical candidate compound with multi-target action against platelet aggregation.
| [1] |
National Cardiovascular Center. China Cardiovascular Health and Disease Report 2019[M]. Beijing: Science Press(科学出版社), 2020: 104-105.
|
| [2] |
Chen R, Xie ML, Zhou J. Experimental study of the inhibition of thrombosis and platelet aggregation[J]. Chin Pharmacol Bull(中国药理学通报), 2005, 21(4): 440-443.
|
| [3] |
Gao LL, Wang F, Chen YJ, et al. The antithrombotic activity of natural and synthetic coumarins[J]. Fitoterapia, 2021, 154: 104947.
|
| [4] |
Zeng GQ, Lin F, Wang XS, et al. Effects of imperatorin and isoimperatorin on platelet aggregation and levels of TXB2 and cAMP in rabbit platelets[J]. Acad J Second Mil Med Univ(第二军医大学学报), 1993, 14(4): 369-370.
|
| [5] |
Hirsch GE, Viecili PRN, de Almeida AS, et al. Natural products with antiplatelet action[J]. Curr Pharm Des, 2017, 23(8): 1228-1246.
|
| [6] |
Chia YC, Chang FR, Wang JC, et al. Antiplatelet aggregation coumarins from the leaves of Murraya omphalocarpa[J]. Molecules, 2008, 13(1): 122-128.
|
| [7] |
Kathuria A, Priya N, Chand K, et al. Substrate specificity of acetoxy derivatives of coumarins and quinolones towards Calreticulin mediated transacetylation: investigations on antiplatelet function[J]. Bioorg Med Chem, 2012, 20(4): 1624-1638.
|
| [8] |
Zaragozá C, Monserrat J, Mantecón C, et al. Antiplatelet activity of flavonoid and coumarin drugs[J]. Vascul Pharmacol, 2016, 87: 139-149.
|
| [9] |
Vilar S, Quezada E, Santana L, et al. Design, synthesis, and vasorelaxant and platelet antiaggregatory activities of coumarin-resveratrol hybrids[J]. Bioorg Med Chem Lett, 2006, 16(2): 257-261.
|
| [10] |
Roma G, Di Braccio M, Grossi G, et al. Synthesis and in vitro antiplatelet activity of new 4-(1-piperazinyl)coumarin derivatives. Human platelet phosphodiesterase 3 inhibitory properties of the two most effective compounds described and molecular modeling study on their interactions with phosphodiesterase 3A catalytic site[J]. J Med Chem, 2007, 50(12): 2886-2895.
|
| [11] |
He LQ, Huang P, Gao LL, et al. Synthesis and biological evaluation of novel coumarin derivatives as antiplatelet agents[J]. Heterocycles, 2016, 92(3): 511.
|
| [12] |
Gao LL. Studies on the design and synthesis of novel coumarin heterocompounds and their antiplatelet aggregation activity[D]. AnHui: AHUCM(安徽中医药大学), 2015.
|
| [13] |
Dai WG, Zhang Z, Huang C, et al. Synthesis and anti-platelet aggregation activity of ethyl coumarin-3-carboxylate derivatives[J]. Chem World (化学世界), 2019, 60(5): 295-299.
|
| [14] |
Shang FY, Dai WG, He B, et al. Synthesis and anti-platelet aggregation activity of 7-nitratoalkoxyl-3-acetyl-coumarin[J]. Chem World (化学世界), 2022, 63(1): 17-21.
|
| [15] |
Shang FY, Ding L, He LQ, et al. Syntheses and anti-platelet aggregation activities of 7-hydroxy-3-acetyl coumarin mannich base derivatives[J]. Chemistry (化学通报), 2022, 85(4): 480-484.
|
| [16] |
Gao Y, Yin W, Liu JC, et al. Design, synthesis and antiplatelet evaluation of tetramethylpyrazine/chalcone hybrids[J]. J China Pharm Univ (中国药科大学学报), 2017, 48(1): 23-30.
|
| [17] |
Dai WG, Tan HZ, Gu HX, et al. Design, synthesis and anti-platelet aggregation activity of paeonol oxime derivatives[J]. J China Pharm Univ (中国药科大学学报), 2022, 53(5): 535-541.
|
| [1] | ZHANG Zhixing, DENG Hua, TANG Yun. Applications and challenges of artificial intelligence in the development of anticancer peptides[J]. Journal of China Pharmaceutical University, 2024, 55(3): 347-356. DOI: 10.11665/j.issn.1000-5048.2024040201 |
| [2] | HU Zi’ang, GAO Liming, YU Wenying. Advances in the application of artificial intelligence in nucleic acid drug development[J]. Journal of China Pharmaceutical University, 2024, 55(3): 335-346. DOI: 10.11665/j.issn.1000-5048.2024033101 |
| [3] | ZENG Hao, WU Guozhen, ZOU Wuxin, WANG Zhe, SONG Jianfei, SHI Hui, WANG Xiaojian, HOU Tingjun, DENG Yafeng. Optimization of Menin inhibitors based on artificial intelligence-driven molecular factory technology[J]. Journal of China Pharmaceutical University, 2024, 55(3): 326-334. DOI: 10.11665/j.issn.1000-5048.2024040904 |
| [4] | JIANG Zhengyu, YOU Qidong. Assistance of artificial intelligence in new drug development[J]. Journal of China Pharmaceutical University, 2024, 55(3): 281-283. DOI: 10.11665/j.issn.1000-5048.2024060302 |
| [5] | XUE Feng, FENG Shuo, LI Jing. Application and prospect of artificial intelligence in antimicrobial peptides screening[J]. Journal of China Pharmaceutical University, 2023, 54(3): 314-322. DOI: 10.11665/j.issn.1000-5048.2023030901 |
| [6] | GU Zhihao, GUO Wenhao, YAO Hequan, LI Xuanyi, LIN Kejiang. Research progress of the screening and generation of lead compounds based on artificial intelligence model[J]. Journal of China Pharmaceutical University, 2023, 54(3): 294-304. DOI: 10.11665/j.issn.1000-5048.2023042201 |
| [7] | YU Zehao, ZHANG Leiming, ZHANG Mengna, DAI Zhiqi, PENG Chengbin, ZHENG Siming. Artificial intelligence-based drug development: current progress and future challenges[J]. Journal of China Pharmaceutical University, 2023, 54(3): 282-293. DOI: 10.11665/j.issn.1000-5048.2023041003 |
| [8] | WANG Chao, XIAO Fu, LI Miaozhu, PAN Ying, DING Xiao, REN Feng, ZHAVORONKOV Alex, WANG Yazhou. Application progress of artificial intelligence in the screening and identification of drug targets[J]. Journal of China Pharmaceutical University, 2023, 54(3): 269-281. DOI: 10.11665/j.issn.1000-5048.2023041102 |
| [9] | YAN Fangrong. Application and advance of artificial intelligence in biomedical field[J]. Journal of China Pharmaceutical University, 2023, 54(3): 263-268. DOI: 10.11665/j.issn.1000-5048.2023030304 |
| [10] | Application of Genechip Technology in Drug Discovery and Development[J]. Journal of China Pharmaceutical University, 2001, (2): 1-6. |
| 1. |
冯馨锐，吴韦铷，张晓丽，杨忠，邓有才，毕清华. 人工智能在临床血液学检验教学中的应用. 中华检验医学杂志. 2025(02): 286-291 .
| |
| 2. |
陈雨欣，付慧，赵熠，徐芳芳，沈甫明. 主动脉夹层发病机制的研究进展. 同济大学学报(医学版). 2025(02): 292-299 .
|
Supported by: Beijing Renhe Information Technology Co., Ltd. 
Total visits：366258
DownLoad: